loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Related Intermediates: CAS 82717-96-2

    Client Email Product
    Menu

    CAS 82717-96-2

    Manufacturers/Suppliers

    PharmaCompass

    Inke S.A: APIs manufacturing plant.

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 PMC Isochem (2)

    02 Zhejiang Huahai Pharmaceutical Co., Ltd. (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    Product-page Product Main Page
    price-trend Ask Us

    PMC Isochem

    Contact Supplier
    • FDA
    • EDQM
    • Audit Compliance
    Virtual BoothPMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    EPAL-NCA

    PDF Supplier PDF
    URL Supplier Web Content
    84793-24-8
    Enalapril Maleate
    PMC Isochem is a CDMO company acquired by PMC International in 2017. It manufactures cGMP intermediates, ...
    PMC Isochem is a CDMO company acquired by PMC International in 2017. It manufactures cGMP intermediates, active pharmaceutical ingredients and functional excipients for pharmaceutical and personal care companies worldwide. Its business includes research, product and process development, pilot-scale, industrial production and regulatory approvals support. It adds value to its clients' intellectual property through constant innovation in manufacturing techniques throughout the product life cycle. PMC Isochem's facilities are located within 60 miles of Paris and are all US FDA-audited plants.
    PMC Isochem

    15th Global DDF Summit

    Booth #33

    envelop Contact Supplier

    PMC Isochem

    Contact Supplier
    • FDA
    • EDQM
    • Audit Compliance
    Virtual BoothPMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Ala-NCA

    PDF Supplier PDF
    URL Supplier Web Content
    2224-52-4
    Enalapril Maleate
    PMC Isochem is a CDMO company acquired by PMC International in 2017. It manufactures cGMP intermediates, ...
    PMC Isochem is a CDMO company acquired by PMC International in 2017. It manufactures cGMP intermediates, active pharmaceutical ingredients and functional excipients for pharmaceutical and personal care companies worldwide. Its business includes research, product and process development, pilot-scale, industrial production and regulatory approvals support. It adds value to its clients' intellectual property through constant innovation in manufacturing techniques throughout the product life cycle. PMC Isochem's facilities are located within 60 miles of Paris and are all US FDA-audited plants.
    PMC Isochem

    15th Global DDF Summit

    Booth #33

    envelop Contact Supplier

    Zhejiang Huahai Pharmaceutical Co.,...

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag China
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-L-alanine N-car...

    PDF Supplier PDF
    URL Supplier Web Content
    84793-24-8
    Enalapril Maleate
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was succe...
    Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Post Enquiry
    POST ENQUIRY